FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies
http://www.fda.gov/news-events/press-announcements/fda-launches-tempo-first-its-kind-digital-health-pilot-expand-access-chronic-disease-technologies

FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US
http://www.fda.gov/news-events/press-announcements/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us

FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
http://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-topical-drug-cattle-new-world-screwworm-and-cattle-fever-tick

FDA Announces Leadership Appointments at Center for Drug Evaluation and Research
http://www.fda.gov/news-events/press-announcements/fda-announces-leadership-appointments-center-drug-evaluation-and-research

FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
http://www.fda.gov/news-events/press-announcements/fda-approves-nerve-scaffold-treatment-sensory-nerve-discontinuity

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/correction-alert-olympus-updates-use-instructions-ligating-device

FDA Seizes 7-OH Opioids to Protect American Consumers
http://www.fda.gov/news-events/press-announcements/fda-seizes-7-oh-opioids-protect-american-consumers

FDA Releases Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies
http://www.fda.gov/news-events/press-announcements/fda-releases-draft-guidance-reducing-testing-non-human-primates-monoclonal-antibodies

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-glucose-monitor-sensor-issue-abbott-diabetes-care

FDA Expands Artificial Intelligence Capabilities with Agentic AI Deployment
http://www.fda.gov/news-events/press-announcements/fda-expands-artificial-intelligence-capabilities-agentic-ai-deployment